Figure - available from: Journal of Cell Biology (JCB)
This content is subject to copyright.
Luciferase sequestration as an assay for in vitro uptake. (A) Luciferase cofractionating with vacuoles is proteinase K protected. In vitro uptake reactions of three times the standard volume were performed (60 min, 27°C) in the presence or absence of the ATP-regenerating system. The vacuoles were reisolated, washed, resuspended in 150 mM KCl in PS buffer to a concentration of 0.23 mg/ml, and split into aliquots. After addition of 1% Triton X-100 or buffer, the mixture was digested with the indicated concentrations of proteinase K (15 min, 0°C). Proteinase treatment was stopped by adding one volume of 0.5 mM PMSF in 150 mM KCl in PS buffer. Then, luciferase activity was assayed. (B) Luciferase can be released from the vacuolar lumen by freeze–thaw treatment. An uptake reaction was performed (60 min, 27°C). The vacuoles were reisolated and washed as described in the Materials and Methods section. The final pellet was resuspended in 90 μl PS buffer with 150 mM KCl and split into two aliquots. One was frozen at −80°C and thawed again slowly, whereas the other remained on ice. The samples were centrifuged (15 min, 145,000 g, 4°C). The supernatants (Sup)were recovered and the pellets were resuspended in an equal volume of PS with 150 mM KCl. Luciferase activity in both fractions was determined. The reaction tubes for this experiment had been coated with BSA (0.5 mg/ml, 15 min at room temperature) to reduce unspecific binding of luciferase to the surface.

Luciferase sequestration as an assay for in vitro uptake. (A) Luciferase cofractionating with vacuoles is proteinase K protected. In vitro uptake reactions of three times the standard volume were performed (60 min, 27°C) in the presence or absence of the ATP-regenerating system. The vacuoles were reisolated, washed, resuspended in 150 mM KCl in PS buffer to a concentration of 0.23 mg/ml, and split into aliquots. After addition of 1% Triton X-100 or buffer, the mixture was digested with the indicated concentrations of proteinase K (15 min, 0°C). Proteinase treatment was stopped by adding one volume of 0.5 mM PMSF in 150 mM KCl in PS buffer. Then, luciferase activity was assayed. (B) Luciferase can be released from the vacuolar lumen by freeze–thaw treatment. An uptake reaction was performed (60 min, 27°C). The vacuoles were reisolated and washed as described in the Materials and Methods section. The final pellet was resuspended in 90 μl PS buffer with 150 mM KCl and split into two aliquots. One was frozen at −80°C and thawed again slowly, whereas the other remained on ice. The samples were centrifuged (15 min, 145,000 g, 4°C). The supernatants (Sup)were recovered and the pellets were resuspended in an equal volume of PS with 150 mM KCl. Luciferase activity in both fractions was determined. The reaction tubes for this experiment had been coated with BSA (0.5 mg/ml, 15 min at room temperature) to reduce unspecific binding of luciferase to the surface.

Source publication
Article
Full-text available
Many organelles change their shape in the course of the cell cycle or in response to environmental conditions. Lysosomes undergo drastic changes of shape during microautophagocytosis, which include the invagination of their boundary membrane and the subsequent scission of vesicles into the lumen of the organelle. The mechanism driving these structu...

Citations

... In yeast, this pathway functions by degrading cytoplasmic components, ER, mitochondria, portions of the nucleus, and lipid droplets [42]. Multiple Atgs are also required for invagination of the lysosomal membrane [44]. The third type is a microautophagic degradation pathway through late endosomes/multivesicular bodies (MVBs). ...
Article
Full-text available
The heat shock factor 1 (HSF1)-mediated stress response pathway and autophagy processes play important roles in the maintenance of proteostasis. Autophagy processes are subdivided into three subtypes: macroautophagy, chaperone-mediated autophagy (CMA), and microautophagy. Recently, molecular chaperones and co-factors were shown to be involved in the selective degradation of substrates by these three autophagy processes. This evidence suggests that autophagy processes are regulated in a coordinated manner by the HSF1-mediated stress response pathway. Recently, various studies have demonstrated that proteostasis pathways including HSF1 and autophagy are implicated in longevity. Furthermore, they serve as therapeutic targets for aging-related diseases such as cancer and neurodegenerative diseases. In the future, these studies will underpin the development of therapies against various diseases.
... Licensing Right NX24OB5K3I, 21 November 2022. During microautophagy, lysosomes take up small cytosolic constituents (soluble or particulate cellular components) by invagination or protrusion of the lysosomal limiting membrane followed by scission [25][26][27][28]. This type of autophagy is non-selective and does not require autophagosome formation. ...
... Quercetin (25), a flavonoid molecule discovered in vegetables, grains, leaves and fruits has exhibited anti-cancer effects on different cancer cells [177][178][179]. Quercetin (25) causes preferential degradation of oncogenic RAS and leads to autophagy in HRAS/Ha-RAS-transformed human colon cells, DLD-1 and HT-29. ...
... Quercetin (25), a flavonoid molecule discovered in vegetables, grains, leaves and fruits has exhibited anti-cancer effects on different cancer cells [177][178][179]. Quercetin (25) causes preferential degradation of oncogenic RAS and leads to autophagy in HRAS/Ha-RAS-transformed human colon cells, DLD-1 and HT-29. Treatment with 3-methyladenine (3-MA), an autophagy inhibitor, inhibits quercetin-induced cell death. ...
Article
Full-text available
Macroautophagy (autophagy) has been a highly conserved process throughout evolution and allows cells to degrade aggregated/misfolded proteins, dysfunctional or superfluous organelles and damaged macromolecules, in order to recycle them for biosynthetic and/or energetic purposes to preserve cellular homeostasis and health. Changes in autophagy are indeed correlated with several pathological disorders such as neurodegenerative and cardiovascular diseases, infections, cancer and inflammatory diseases. Conversely, autophagy controls both apoptosis and the unfolded protein response (UPR) in the cells. Therefore, any changes in the autophagy pathway will affect both the UPR and apoptosis. Recent evidence has shown that several natural products can modulate (induce or inhibit) the autophagy pathway. Natural products may target different regulatory components of the autophagy pathway, including specific kinases or phosphatases. In this review, we evaluated ~100 natural compounds and plant species and their impact on different types of cancers via the autophagy pathway. We also discuss the impact of these compounds on the UPR and apoptosis via the autophagy pathway. A multitude of preclinical findings have shown the function of botanicals in regulating cell autophagy and its potential impact on cancer therapy; however, the number of related clinical trials to date remains low. In this regard, further pre-clinical and clinical studies are warranted to better clarify the utility of natural compounds and their modulatory effects on autophagy, as fine-tuning of autophagy could be translated into therapeutic applications for several cancers.
... Licensing Right NX24OB5K3I, 21 November 2022. During microautophagy, lysosomes take up small cytosolic constituents (soluble or particulate cellular components) by invagination or protrusion of the lysosomal limiting membrane followed by scission [25][26][27][28]. This type of autophagy is non-selective and does not require autophagosome formation. ...
... Quercetin (25), a flavonoid molecule discovered in vegetables, grains, leaves and fruits has exhibited anti-cancer effects on different cancer cells [177][178][179]. Quercetin (25) causes preferential degradation of oncogenic RAS and leads to autophagy in HRAS/Ha-RAS-transformed human colon cells, DLD-1 and HT-29. ...
... Quercetin (25), a flavonoid molecule discovered in vegetables, grains, leaves and fruits has exhibited anti-cancer effects on different cancer cells [177][178][179]. Quercetin (25) causes preferential degradation of oncogenic RAS and leads to autophagy in HRAS/Ha-RAS-transformed human colon cells, DLD-1 and HT-29. Treatment with 3-methyladenine (3-MA), an autophagy inhibitor, inhibits quercetin-induced cell death. ...
Article
Full-text available
Macroautophagy (autophagy) has been a highly conserved process throughout evolution and allows cells to degrade aggregated/misfolded proteins, dysfunctional or superfluous organelles and damaged macromolecules, in order to recycle them for biosynthetic and/or energetic purposes to preserve cellular homeostasis and health. Changes in autophagy are indeed correlated with several pathological disorders such as neurodegenerative and cardiovascular diseases, infections, cancer and inflammatory diseases. Conversely, autophagy controls both apoptosis and the unfolded protein response (UPR) in the cells. Therefore, any changes in the autophagy pathway will affect both the UPR and apoptosis. Recent evidence has shown that several natural products can modulate (induce or inhibit) the autophagy pathway. Natural products may target different regulatory components of the autophagy pathway, including specific kinases or phosphatases. In this review, we evaluated ~100 natural compounds and plant species and their impact on different types of cancers via the autophagy pathway. We also discuss the impact of these compounds on the UPR and apoptosis via the autophagy pathway. A multitude of preclinical findings have shown the function of botanicals in regulating cell autophagy and its potential impact on cancer therapy; however, the number of related clinical trials to date remains low. In this regard, further pre-clinical and clinical studies are warranted to better clarify the utility of natural compounds and their modulatory effects on autophagy, as fine-tuning of autophagy could be translated into therapeutic applications for several cancers.
... Microautophagic vesicle formation is related more to the formation of multivesicular bodies; that is, the formation of internal endosomal vesicles enriched in a specialized lipid (lysobisphosphatidic acid) that plays an essential role in the budding of vesicles into the vacuolar lumen. Vesicle budding into the vacuolar lumen occurs independently of the vacuolar SNARE proteins Vam3p, Vam7p, Nyv1p, Sec18p, and Sec17p [33,34]. ...
Article
Full-text available
Autophagy is a highly conserved lysosomal degradation pathway active at basal levels in all cells. However, under stress conditions, such as a lack of nutrients or trophic factors, it works as a survival mechanism that allows the generation of metabolic precursors for the proper functioning of the cells until the nutrients are available. Neurons, as post-mitotic cells, depend largely on autophagy to maintain cell homeostasis to get rid of damaged and/or old organelles and misfolded or aggregated proteins. Therefore, the dysfunction of this process contributes to the pathologies of many human diseases. Furthermore, autophagy is highly active during differentiation and development. In this review, we describe the current knowledge of the different pathways, molecular mechanisms, factors that induce it, and the regulation of mammalian autophagy. We also discuss its relevant role in development and disease. Finally, here we summarize several investigations demonstrating that autophagic abnormalities have been considered the underlying reasons for many human diseases, including liver disease, cardiovascular, cerebrovascular diseases, neurodegenerative diseases, neoplastic diseases, cancers, and, more recently, infectious diseases, such as SARS-CoV-2 caused COVID-19 disease.
... First is the constitutive invagination of the membrane of the lysosome/endosome, leading to the creation of an autophagic tube, a process that is upregulated under cellular starvation [60]. The formation of autophagic tubes is an active process, requiring the use of adenosine triphosphate (ATP) by vacuolar ATPases, and it is mediated by dynamin related GTPase Vps1p [61,62]. Starvation-induced mA is regulated via Atg7-dependednt ubiquitin-like conjugation (Ublc) systems that mediate membrane tethering [63,64]. ...
... Vesicle formation involves the sorting of membrane constituents with high-lipid and low-protein composition at the top of the autophagic tube [60]. Then, the vesicle binds with enzymes, implicating a reverse of the endocytosis process, and expanding the cytoplasmic leaflet [62]. Such vesicles have tendency to pinch themselves off into the lysosomal/endosomal lumen from the autophagic tube, and this vesicle scission does not require the various machinery required for MA [66]. ...
Article
Full-text available
Autophagy, a cellular self-digestion process, involves the degradation of targeted cell components such as damaged organelles, unfolded proteins, and intracellular pathogens by lysosomes. It is a major quality control system of the cell and plays an important role in cell differentiation, survival, development, and homeostasis. Alterations in the cell autophagic machinery have been implicated in several disease conditions, including neurodegeneration, autoimmunity, cancer, infection, inflammatory diseases, and aging. In non-alcoholic fatty liver disease, including its inflammatory form, non-alcoholic steatohepatitis (NASH), a decrease in cell autophagic activity, has been implicated in the initial development and progression of steatosis to NASH and hepatocellular carcinoma (HCC). We present an overview of autophagy as it occurs in mammalian cells with an insight into the emerging understanding of the role of autophagy in NASH and NASH-related HCC.
... Microautophagy directly degrades cytoplasmic cargos by lysosomal/vacuolar engulfment of them for degradation in lysosomal/vacuolar lumen. [5][6][7] In microautophagy, endosomal sorting complex required for transport (ESCRT) executes vacuolar membrane deformation and remodelling. [8][9][10][11] The priming ESCRT-0 complex is recruited onto the membrane, and gathers the ESCRT-I and -II complexes, promoting the recruitment of ESCRT-III, which promotes the invagination, constriction, and abscission of membranes. ...
Article
Phosphatidylinositol 3-phosphate (PI3P), a scaffold of membrane-associated proteins required for diverse cellular events, is produced by Vps34-containing phosphatidylinositol 3-kinase (PI3K). PI3K complex I (PI3KCI)-generated PI3P is required for macroautophagy, whereas PI3K complex II (PI3KCII)-generated PI3P is required for endosomal sorting complex required for transport (ESCRT)-mediated multi-vesicular body (MVB) formation in late endosomes. ESCRT also promotes vacuolar membrane remodeling in microautophagy after nutrient starvation and inactivation of target of rapamycin complex 1 (TORC1) protein kinase in budding yeast. Whereas PI3KCI and macroautophagy are critical for the nutrient starvation response, the physiological roles of PI3KCII and microautophagy during starvation are largely unknown. Here, we showed that PI3KCII-produced PI3P on vacuolar membranes is required for microautophagy induction and survival in nutrient-stressed conditions. PI3KCII is required for Vps27 (an ESCRT-0 component) recruitment and ESCRT-0 complex formation on vacuolar surfaces after TORC1 inactivation. Forced recruitment of Vps27 onto vacuolar membranes rescued the defect in microautophagy induction in PI3KCII-deficient cells, indicating that a critical role of PI3P on microautophagy induction is Vps27 recruitment onto vacuolar surfaces. Finally, vacuolar membrane-associated Vps27 was able to recover survival during nutrient starvation in cells lacking PI3KCII or Vps27. This study revealed that the PI3KCII–PI3P–Vps27 axis on vacuolar membranes is critical for ESCRT-mediated microautophagy induction and nutrient stress adaptation.
... Finally, autophagosomes fuse with the vacuole and their cargoes are digested by vacuolar hydrolases. In contrast to macroautophagy, microautophagy degrades cargoes via the direct vacuolar engulfment, with or without the formation of an additional autophagic membrane [111][112][113]. Microautophagy can selectively degrade various specific cargos, such as the nucleus, peroxisomes, mitochondria, ER, and LDs, in the yeasts S. cerevisiae and K. phaffii [34,[114][115][116][117]. ...
... Microlipophagy needs the entire core autophagic machinery, including the Atg1 kinase complex (except Atg11), phosphatidylinositol 3-kinase (PI3K) complex I components, Atg9 cycling system, and Atg8/Atg12 conjugation systems under various conditions tested [33,34,118]. In early studies of yeast microautophagy, it was shown that vacuolar invaginations and uptake of solutes during acute nitrogen starvation depend on the core Atg-factors both in vitro and in vivo [112,113]. However, it was proposed that the role of Atg-factors is indirect. ...
Article
Full-text available
Although once perceived as inert structures that merely serve for lipid storage, lipid droplets (LDs) have proven to be the dynamic organelles that hold many cellular functions. The LDs’ basic structure of a hydrophobic core consisting of neutral lipids and enclosed in a phospholipid monolayer allows for quick lipid accessibility for intracellular energy and membrane production. Whereas formed at the peripheral and perinuclear endoplasmic reticulum, LDs are degraded either in the cytosol by lipolysis or in the vacuoles/lysosomes by autophagy. Autophagy is a regulated breakdown of dysfunctional, damaged, or surplus cellular components. The selective autophagy of LDs is called lipophagy. Here, we review LDs and their degradation by lipophagy in yeast, which proceeds via the micrometer-scale raft-like lipid domains in the vacuolar membrane. These vacuolar microdomains form during nutrient deprivation and facilitate internalization of LDs via the vacuolar membrane invagination and scission. The resultant intra-vacuolar autophagic bodies with LDs inside are broken down by vacuolar lipases and proteases. This type of lipophagy is called microlipophagy as it resembles microautophagy, the type of autophagy when substrates are sequestered right at the surface of a lytic compartment. Yeast microlipophagy via the raft-like vacuolar microdomains is a great model system to study the role of lipid domains in microautophagic pathways
... (micropexophagy) and parts of the nucleus (piecemeal microautophagy of the nucleus) have been described [23][24][25]. The molecular machineries of microautophagy and macroautophagy overlap, as several core macroautophagy factors have been reported to play a role also in microautophagy, including Atg1 [26][27][28][29]. ...
Article
Full-text available
Adequate dietary calcium (Ca) intake is essential for bone accretion, peak bone mass (PBM) attainment, bone quality and strength during the mammalian growth period. Severe Ca deficiency during growing age results in secondary hyperparathyroidism (SHPT) and poor bone quality and strength. However, the impact of moderate Ca deficiency during rats early growth period on bone health and the reversibility with supplementing calcium later in adult life remains unclear. Female Sprague-Dawley (SD) rats (postnatal 28th day, P28) were initiated either with a moderate calcium-deficient diet (MCD, 0.25% w/w Ca) or a control diet (0.8% w/w Ca, control group) till P70. Thereafter, MCD rats were continued either with MCD diet or supplemented with calcium diet (0.8% w/w Ca, calcium supplemented group, CaS) till P150. Another group (control rats) were fed 0.8% w/w Ca containing diet from P28 till P150. MCD group, as compared to the control group, had significantly reduced serum ionized Ca and procollagen type 1 N-terminal propeptide (P1NP) at P70 while no significant change was observed in serum corrected Ca, inorganic phosphate (P), alkaline phosphatase (ALP), 25-hydroxy vitamin D [25(OH)D], intact parathyroid hormone (iPTH), and urinary C-terminal telopeptide of collagen 1 (CTX-1), Ca, and P. Femoral and tibial metaphysis in MCD rats had significantly reduced linear growth, cortical and trabecular volumetric BMD (vBMD), trabecular microarchitecture (BV/TV%, trabecular thickness, separation and number, structural model index and connectivity density), cortical thickness, and bone stiffness despite the absence of secondary hyperparathyroidism (SHPT). Continued MCD at P70–P150 results in persistence of compromised bone strength while calcium supplementation (CaS group) improved all the parameters related to bone strength and microarchitecture. Our results indicate that uncorrected moderate/subclinical calcium deficiency in growing rats can result in poor bone quality and strength despite the absence of SHPT. This finding could have relevance in children with poor calcium intake in childhood and adolescence.
... In microautophagy, cytoplasmic cargos are directly engulfed by lysosomal/vacuolar membranes, sorted into the vacuolar lumen, and degraded [1][2][3]. Because vacuolar membrane proteins together with vacuolar membranes are degraded in the vacuole in the course of microautophagy, overall microautophagic flux is estimated using green fluorescent protein (GFP)-tagged vacuolar transmembrane proteins, Vph1 (a subunit of the vacuolar-ATPase V0 domain) and Pho8 (vacuolar alkaline phosphatase) in the budding yeast Saccharomyces cerevisiae [4]. ...
Article
Full-text available
Background: Microautophagy, which degrades cargos by direct lysosomal/vacuolar engulfment of cytoplasmic cargos, is promoted after nutrient starvation and the inactivation of target of rapamycin complex 1 (TORC1) protein kinase. In budding yeast, microautophagy has been commonly assessed using processing assays with green fluorescent protein (GFP)-tagged vacuolar membrane proteins, such as Vph1 and Pho8. The endosomal sorting complex required for transport (ESCRT) system is proposed to be required for microautophagy, because degradation of vacuolar membrane protein Vph1 was compromised in ESCRT-defective mutants. However, ESCRT is also critical for the vacuolar sorting of most vacuolar proteins, and hence reexamination of the involvement of ESCRT in microautophagic processes is required. Results: Here, we show that the Vph1-GFP processing assay is unsuitable for estimating the involvement of ESCRT in microautophagy, because Vph1-GFP accumulated highly in the prevacuolar class E compartment in ESCRT mutants. In contrast, GFP-Pho8 and Sna4-GFP destined for vacuolar membranes via an alternative adaptor protein-3 (AP-3) pathway, were properly localized on vacuolar membranes in ESCRT-deficient cells. Nevertheless, microautophagic degradation of GFP-Pho8 and Sna4-GFP after TORC1 inactivation was hindered in ESCRT mutants, indicating that ESCRT is indeed required for microautophagy after nutrient starvation and TORC1 inactivation. Conclusions: These findings provide evidence for the direct role of ESCRT in microautophagy induction.
... Whether autophagic tube formation involves ESCRTs has not been tested. It is reduced, however, upon disruption of the core autophagy machinery (Müller et al., 2000;Sattler and Mayer, 2000). This finding suggests an indirect role of the core autophagy machinery, possibly resulting from an interplay between macroautophagy and microautophagy in maintaining vacuole membrane homeostasis (Müller et al., 2000). ...
Article
Full-text available
Autophagy is fundamental for cell and organismal health. Two types of autophagy are conserved in eukaryotes: macroautophagy and microautophagy. During macroautophagy, autophagosomes deliver cytoplasmic constituents to endosomes or lysosomes, whereas during microautophagy lytic organelles take up cytoplasm directly. While macroautophagy has been investigated extensively, microautophagy has received much less attention. Nonetheless, it has become clear that microautophagy has a broad range of functions in biosynthetic transport, metabolic adaptation, organelle remodeling and quality control. This Review discusses the selective and non-selective microautophagic processes known in yeast, plants and animals. Based on the molecular mechanisms for the uptake of microautophagic cargo into lytic organelles, I propose to distinguish between fission-type microautophagy, which depends on ESCRT proteins, and fusion-type microautophagy, which requires the core autophagy machinery and SNARE proteins. Many questions remain to be explored, but the functional versatility and mechanistic diversity of microautophagy are beginning to emerge.